Background: An early detection tool for EOC was constructed from analysis of biomarker expression data from serum collected during the UKCTOCS. Methods: This study included 49 EOC cases (19 Type I and 30 Type II) and 31 controls, representing 482 serial samples spanning seven years pre-diagnosis. A logit model was trained by analysis of dysregulation of expression data of four putative biomarkers, (CA125, phosphatidylcholine-sterol acyltransferase, vitamin K-dependent protein Z and C-reactive protein); by scoring the specificity associated with dysregulation from the baseline expression for each individual. Results: The model is discriminatory, passes k-fold and leave-one-out cross-validations and was further validated in a Type I EOC set. Samples were analysed as a simulated annual screening programme, the algorithm diagnosed cases with >30% PPV 1–2 years pre-diagnosis. For Type II cases (~80% were HGS) the algorithm classified 64% at 1 year and 28% at 2 years tDx as severe. Conclusions: The panel has the potential to diagnose EOC one-two years earlier than current diagnosis. This analysis provides a tangible worked example demonstrating the potential for development as a screening tool and scrutiny of its properties. Limits on interpretation imposed by the number of samples available are discussed.
Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel / M.R. Russell, C. Graham, A. D'Amato, A. Gentry-Maharaj, A. Ryan, J.K. Kalsi, A.D. Whetton, U. Menon, I. Jacobs, R.L.J. Graham. - In: BRITISH JOURNAL OF CANCER. - ISSN 0007-0920. - 121:6(2019 Sep), pp. 483-489.
|Titolo:||Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel|
|Settore Scientifico Disciplinare:||Settore CHIM/01 - Chimica Analitica|
Settore BIO/10 - Biochimica
|Data di pubblicazione:||set-2019|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1038/s41416-019-0544-0|
|Appare nelle tipologie:||01 - Articolo su periodico|